Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer-Reference-Cited by-同舟云学术

Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer

Published:2015-09-18 Issue:3 Volume:22 Page:714-724
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Wouters Maartje C.A.,Komdeur Fenne L.,Workel Hagma H.,Klip Harry G.,Plat Annechien,Kooi Neeltje M.,Wisman G. Bea A.,Mourits Marian J.E.,Arts Henriette J.G.,Oonk Maaike H.M.,Yigit Refika,de Jong Steven,Melief Cornelis J.M.,Hollema Harry,Duiker Evelien W.,Daemen Toos,de Bruyn Marco,Nijman Hans W.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cells critical for outcome in high grade serous ovarian carcinoma;International Journal of Cancer;2024-08-22

2. The profile and prognostic significance of bone marrow T-cell differentiation subsets in adult AML at diagnosis;Frontiers in Immunology;2024-07-19

3. The Impact of Neoadjuvant Chemotherapy on Ovarian Cancer Tumor Microenvironment: A Systematic Review of the Literature;International Journal of Molecular Sciences;2024-06-27

4. Predicting CD27 expression and clinical prognosis in serous ovarian cancer using CT-based radiomics;Journal of Ovarian Research;2024-06-22

5. Prognostic Impact of Tumor-Infiltrating Immune Cells on Efficacy of Neoadjuvant Chemotherapy in Patients with Advanced or Metastatic Ovarian Cancer: A Retrospective Study;Medical Science Monitor;2024-06-13